跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LETERO (LETROZOLE) TABLETS 2.5 MG - HSA Drug Approval Details
Approvals
/
HSA
/
LETERO (LETROZOLE) TABLETS 2.5 MG
Approved
THERAPEUTIC
LETERO (LETROZOLE) TABLETS 2.5 MG
HETERO LABS LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Dec 30, 2014
Approval ID
a2543e5cfd1cf705
Company
HETERO LABS LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
a2543e5cfd1cf705
Drug Name
LETERO (LETROZOLE) TABLETS 2.5 MG
Product Name
LETERO (LETROZOLE) TABLETS 2.5 MG
Approval Number
SIN14717P
Approval Date
2014-12-30
Registrant
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Licence Holder
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
L02BG04
Atc Item Name
letrozole
Pharma Manufacturer Name
MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Company Detail Path
/organization/medicell-pharmaceutical-s-pte-ltd
Active Ingredients
Letrozole
2.500 mg
LETROZOLE
2.5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 30, 2014
Approval ID
a2543e5cfd1cf705
Type
Therapeutic
Back to HSA Approvals